BACKGROUND End-stage renal disease is a long-term irreversible decline in kidney
function requiring kidney transplantation, haemodialysis or peritoneal dialysis. The preferred …

This study evaluated the efficacy of prophylactic ValGCV in preventing CMV and EBV
infections in a single‐center pediatric kidney transplant population (2008‐2014). Therapy …

Background CMV is associated with adverse effects in renal transplant recipients. The
objective of this study was to characterize the incidence and timing of CMV and EBV …

Solid organ transplantation is a life-saving procedure that has changed the prognosis for
infants and children with end-stage organ disease. Cytomegalovirus (CMV) is one of the …

Despite prevention strategies, cytomegalovirus (CMV) remains a common infection in
pediatric solid organ transplant recipients (SOTR). We sought to determine the frequency …

End‐organ disease caused by CMV is a significant cause of morbidity and mortality in
pediatric SOT recipients. Pediatric transplant centers have adopted various approaches for …

Methods: In this cross-sectional study 160 children diagnosed by ALL in Ali-Asghar Children
Hospital, Tehran (1996-2010) were recruited. TLS was defined as having two or more of the …

Background. Valganciclovir has been widely used for cytomegalovirus (CMV) prophylaxis in
solid-organ transplant recipients. However, the optimal dosing protocol and target exposure …

Optimal strategies to prevent cytomegalovirus (CMV) disease following pediatric solid organ
transplantation remain controversial. The purpose of this study was to review the outcomes …

Cytomegalovirus is common in adult recipients (prevalence of 40–90%). Children are
typically seronegative but immunosuppression may prone to primary-infection or viral …